Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion type Assertion NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_head.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion evidence source_evidence_literature NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion SIO_000772 17909009 NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion wasDerivedFrom befree-2016 NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion wasGeneratedBy ECO_0000203 NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.